RFA: Common Mechanisms in Autoimmunity Insight Awards
Supports studies on common autoimmune mechanisms to inform shared treatment strategies for type 1 diabetes and related conditions.
Breakthrough T1D — formerly JDRF, rebranded June 2024 — is a 501(c)(3) nonprofit that has funded T1D research since 1970 and estimates 9.5 million people worldwide live with the condition. Its FY26 topic-specific RFA titled "Common Mechanisms in Autoimmunity Insight Awards" solicits research identifying shared mechanistic pathways across autoimmune diseases that yield translational insights releva…
Research into shared mechanistic pathways across autoimmune diseases that yield translational insights relevant to the prevention or treatment of type 1 diabetes.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline